CT radiologic findings in patients with tuberculous destroyed lung and correlation with lung function

Tuberculosis and Respiratory Diseases

Volumn 71, Issue 3, 2011, Pages 202-209

  Chae, Jin Nyeong ^a   Jung, Chi Young ^a   Shim, Sang Woo ^a   Rho, Byung Hak ^a   Jeon, Young June ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

Bronchiectasis; Lung diseases, obstructive; Tuberculosis; Tuberculosis, pulmonary complications

Indexed keywords

AIRWAY; ARTICLE; BRONCHIECTASIS; CIGARETTE SMOKING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG TUBERCULOSIS; RETROSPECTIVE STUDY;

EID: 80054791117     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2011.71.3.202     Document Type: Article

References (28)

1. World Health Organization (WHO). Tuberculosis (TB): global tuberculosis control 2010. Geneva, Switzerland: WHO; c2011 [cited 2011 Sep 16]. Available from: http://www.who.int/tb/publications/global-report/2010/en.
2. Bobrowitz ID, Rodescu D, Marcus H, Abeles H. The destroyed tuberculous lung. Scand J Respir Dis 1974;55:82-8.
3. Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med 2003;97:1237-42. (Pubitemid 37337022)
4. Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med 1989;83:195-8. (Pubitemid 19207193)
5. Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway disease in patients with treated pulmonary tuberculosis. Am Rev Respir Dis 1971;103:625-40.
6. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000;55:32-8. (Pubitemid 30248776)
7. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, et al. Pulmonary impairment after tuberculosis. Chest 2007;131:1817-24. (Pubitemid 46981640)
8. Plit ML, Anderson R, Van Rensburg CE, Page-Shipp L, Blott JA, Fresen JL, et al. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J 1998;12:351-6. (Pubitemid 28389528)
9. Lam KB, Jiang CQ, Jordan RE, Miller MR, Zhang WS, Cheng KK, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest 2010;137:593-600.
10. Lee SW, Kim YS, Kim DS, Oh YM, Lee SD. The risk of obstructive lung disease by previous pulmonary tuberculosis in a country with intermediate burden of tuberculosis. J Korean Med Sci 2011;26:268-73.
11. Lee BH, Kim YS, Lee KD, Lee JH, Kim SH. Health-related quality of life measurement with St. George's respiratory questionnaire in post-tuberculous destroyed lung. Tuberc Respir Dis 2008;65:183-90.
12. Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis 2011;15:246-50.
13. Kim HY, Song KS, Goo JM, Lee JS, Lee KS, Lim TH. Thoracic sequelae and complications of tuberculosis. Radiographics 2001;21:839-58.
14. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
15. The global initiative for chronic obstructive lung disease (GOLD). GOLD [Homepage]. GOLD; C2010-2011 [cited 2011 Sep 17]. Available from: http://www.goldcopd.org.
16. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen N. Pulmonary tuberculosis treated with directly observed therapy: serial changes in lung structure and function. Chest 1998;113:933-43. (Pubitemid 28216435)
17. Im JG, Itoh H, Lee KS, Han MC. CT-pathology correlation of pulmonary tuberculosis. Crit Rev Diagn Imaging 1995;36:227-85.
18. Ashour M, Pandya L, Mezraqji A, Qutashat W, Desouki M, al-Sharif N, et al. Unilateral post-tuberculous lung destruction: the left bronchus syndrome. Thorax 1990;45:210-2. (Pubitemid 20108726)
19. Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006;61:259-66.
20. Jordan TS, Spencer EM, Davies P. Tuberculosis, bronchiectasis and chronic airflow obstruction. Respirology 2010;15:623-8.
21. Cleverley JR, Müller NL. Advances in radiologic assessment of chronic obstructive pulmonary disease. Clin Chest Med 2000;21:653-63. (Pubitemid 32057584)
22. Madani A, Keyzer C, Gevenois PA. Quantitative computed tomography assessment of lung structure and function in pulmonary emphysema. Eur Respir J 2001;18:720-30. (Pubitemid 33040632)
23. Kinsella M, Müller NL, Abboud RT, Morrison NJ, DyBuncio A. Quantitation of emphysema by computed tomography using a "density mask" program and correlation with pulmonary function tests. Chest 1990;97:315-21. (Pubitemid 20050666)
24. Pande JN, Jain BP, Gupta RG, Guleria JS. Pulmonary ventilation and gas exchange in bronchiectasis. Thorax 1971;26:727-33.
25. Loubeyre P, Paret M, Revel D, Wiesendanger T, Brune J. Thin-section CT detection of emphysema associated with bronchiectasis and correlation with pulmonary function tests. Chest 1996;109:360-5. (Pubitemid 26058589)
26. Roberts HR, Wells AU, Milne DG, Rubens MB, Kolbe J, Cole PJ, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax 2000;55:198-204. (Pubitemid 30245969)
27. Kim YJ, Park JY, Won JH, Kim CH, Rang DS, Jung TH. Lung volumes and diffusing capacity in bronchiectasis: correlation with the findings of high resolutional CT. Tuberc Respir Dis 1999;46:489-99.
28. Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchial anthracofibrosis: presenting features and clinical course. Respir Med 2009;103:757-65.